Key facts
- Notable investors include Abingworth.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Dirigent Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Dirigent Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dirigent Bio
Developer of a precision therapy designed to treat autoimmune disease by targeting the underlying biological drivers of autoimmunity. This company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Altrincham, United Kingdom
- Founded
- 2025
- Ownership
- Privately Held (backing)
Dirigent Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dirigent Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dirigent Bio in its N-PORT filings yet. We sweep new filings monthly.